Your browser doesn't support javascript.
loading
A phase 1 trial of oncolytic HSV-1, G207, given in combination with radiation for recurrent GBM demonstrates safety and radiographic responses.
Markert, James M; Razdan, Shantanu N; Kuo, Hui-Chien; Cantor, Alan; Knoll, Anette; Karrasch, Matthias; Nabors, L Burt; Markiewicz, Michael; Agee, Bonita S; Coleman, Jennifer M; Lakeman, Alfred D; Palmer, Cheryl A; Parker, Jacqueline N; Whitley, Richard J; Weichselbaum, Ralph R; Fiveash, John B; Gillespie, G Yancey.
Afiliação
  • Markert JM; 1] Department of Neurosurgery, University of Alabama at Birmingham, Birmingham, Alabama, USA [2] Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA [3] Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, Ala
  • Razdan SN; School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Kuo HC; Department of Medicine, Division of Preventative Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Cantor A; Department of Medicine, Division of Preventative Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Knoll A; AK Statistics, Bavaria, Germany.
  • Karrasch M; Institute of Medical Microbiology, University Hospital of Friedrich-Schiller-University, Jena, Germany.
  • Nabors LB; Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Markiewicz M; School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Agee BS; Department of Neurosurgery, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Coleman JM; Department of Neurosurgery, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Lakeman AD; Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Palmer CA; Department of Pathology, Division of Anatomic Pathology, The University of Utah, Salt Lake City, Utah, USA.
  • Parker JN; 1] Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA [2] Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Whitley RJ; 1] Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, Alabama, USA [2] Department of Microbiology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Weichselbaum RR; Department of Radiation Oncology, University of Chicago, Chicago, Illinois, USA.
  • Fiveash JB; Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Gillespie GY; 1] Department of Neurosurgery, University of Alabama at Birmingham, Birmingham, Alabama, USA [2] Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, Alabama, USA [3] Department of Microbiology, University of Alabama at Birmingham, Birmingham, A
Mol Ther ; 22(5): 1048-55, 2014 May.
Article em En | MEDLINE | ID: mdl-24572293
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Terapia Genética / Herpesvirus Humano 1 / Glioma Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Terapia Genética / Herpesvirus Humano 1 / Glioma Idioma: En Ano de publicação: 2014 Tipo de documento: Article